P
The startup develops immunotherapy drugs and vaccines specifically for companion animals, focusing on targeted treatments for canine cancer. By utilizing advanced immunological techniques, the company aims to improve the efficacy of cancer therapies and enhance the quality of life for pets suffering from this disease.
Taipei, Taiwan
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops immunotherapy drugs and vaccines specifically for companion animals, focusing on targeted treatments for canine cancer. By utilizing advanced immunological techniques, the company aims to improve the efficacy of cancer therapies and enhance the quality of life for pets suffering from this disease.